Search in:

Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 9

Submit an article Journal homepage

275

Views

CrossRef citations to date

Altmetric

Review

Management and control strategies for community-associated methicillin-resistant Staphylococcus aureus

Edina Avdic Clinical Pharmacy Specialist, Associate Director, Antibiotic Management Program The Johns Hopkins Hospital, Department of Pharmacy, Osler 425, 600 North Wolfe Street, Baltimore, MD 21287, USA +1 443 287 4570; +1 410 614 0888; [email protected]

, PharmD MBA &

Sara E Cosgrove Assistant Professor of Medicine, Director, Antibiotic Management Program Johns Hopkins Medical Institutions, Division of Infectious Diseases, Osler 425, 600 North Wolfe Street, Baltimore, MD 21287, USA

, MD MS

Pages 1463-1479 | Published online: 02 Jun 2008

Cite this article
https://doi.org/10.1517/14656566.9.9.1463

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Bibliography

Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus – Minnesota and North Dakota, 1997 – 1999. MMWR Morb Mortal Wkly Rep 1999;48:707-10
PubMedGoogle Scholar
Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763-71
PubMed Web of Science ®Google Scholar
Saiman L, O'Keefe M, Graham PL III, et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 2003;37:1313-9
PubMed Web of Science ®Google Scholar
Kourbatova EV, Halvosa JS, King MD, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 2005;33:385-91
PubMed Web of Science ®Google Scholar
Seybold U, Kourbatova EV, Johnson JG, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006;42:647-56
PubMed Web of Science ®Google Scholar
Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-84
PubMed Web of Science ®Google Scholar
Crum NF, Lee RU, Thornton SA, et al. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med 2006;119:943-51
PubMed Web of Science ®Google Scholar
Ellis MW, Hospenthal DR, Dooley DP, et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004;39:971-9
PubMed Web of Science ®Google Scholar
Lowy FD, Aiello AE, Bhat M, et al. Staphylococcus aureus colonization and infection in New York state prisons. J Infect Dis 2007;196:911-8
PubMed Web of Science ®Google Scholar
Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666-74
PubMed Web of Science ®Google Scholar
Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-44
PubMed Web of Science ®Google Scholar
Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005;352:1445-53
PubMed Web of Science ®Google Scholar
Pannaraj PS, Hulten KG, Gonzalez BE, et al. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2006;43:953-60
PubMed Web of Science ®Google Scholar
Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005;115:642-8
PubMed Web of Science ®Google Scholar
Adem PV, Montgomery CP, Husain AN, et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med 2005;353:1245-51
PubMed Web of Science ®Google Scholar
Mongkolrattanothai K, Boyle S, Kahana MD, Daum RS. Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clin Infect Dis 2003;37:1050-8
PubMed Web of Science ®Google Scholar
Fitch MT, Manthey DE, McGinnis HD, et al. Videos in clinical medicine. Abscess incision and drainage. N Engl J Med 2007;357:e20
PubMed Web of Science ®Google Scholar
Hankin A, Everett WW. Are antibiotics necessary after incision and drainage of a cutaneous abscess? Ann Emerg Med 2007;50:49-51
PubMed Web of Science ®Google Scholar
Rajendran PM, Young DM, Maurer T, et al. Antibiotic use in the treatment of soft tissue abscesses: a survey of current practice. Surg Infect (Larchmt) 2007;8:237-8
PubMedGoogle Scholar
Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004;23:123-7
PubMed Web of Science ®Google Scholar
Young DM, Harris HW, Charlebois ED, et al. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg 2004;139:947-51; discussion 951-3
PubMed Web of Science ®Google Scholar
Miller LG, Quan C, Shay A, et al. A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clin Infect Dis 2007;44:483-92
PubMed Web of Science ®Google Scholar
Rajendran PM, Young D, Maurer T, et al. Randomised, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother 2007;51:4044-8
PubMed Web of Science ®Google Scholar
Ruhe JJ, Smith N, Bradsher RW, Menon A. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis 2007;44:777-84
PubMed Web of Science ®Google Scholar
Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA; Participants in the CDC Convened Experts' Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention. 2006. Available from: http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html [Last accessed 3rd May 2008]
Google Scholar
Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc 2007;138:739-45, 747-60
PubMed Web of Science ®Google Scholar
Schneider-Lindner V, Delaney J, Dial S, et al. Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom. Emerg Infect Dis 2007;13:994-1000
PubMed Web of Science ®Google Scholar
Han LL, McDougal LK, Gorwitz RJ, et al. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center. J Clin Microbiol 2007;45:1350-2
PubMed Web of Science ®Google Scholar
Kaka AS, Rueda AM, Shelburne SA III, et al. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2006;58:680-3
PubMed Web of Science ®Google Scholar
Szumowski JD, Cohen DE, Kanaya F, Mayer KH. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother 2007;51:423-8
PubMed Web of Science ®Google Scholar
Stein A, Bataille JF, Drancourt M, et al. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 1998;42:3086-91
PubMed Web of Science ®Google Scholar
Iyer S, Jones DH. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak. J Am Acad Dermatol 2004;50:854-8
PubMed Web of Science ®Google Scholar
Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 1992;117:390-8
PubMed Web of Science ®Google Scholar
Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005;40:1785-91
PubMed Web of Science ®Google Scholar
Martinez-Aguilar G, Hammerman WA, Mason EO Jr, Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 2003;22:593-8
PubMed Web of Science ®Google Scholar
Siberry GK, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 2003;37:1257-60
PubMed Web of Science ®Google Scholar
Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003;41:4740-4
PubMed Web of Science ®Google Scholar
Minuth JN, Holmes TM, Musher DM. Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and -resistant staphylococci. Antimicrob Agents Chemother 1974;6:411-4
PubMed Web of Science ®Google Scholar
Ruhe JJ, Menon A. Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2007;51:3298-303
PubMed Web of Science ®Google Scholar
Weigelt J, Itani K, Stevens D, et al. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother 2005;49:2260-6
PubMed Web of Science ®Google Scholar
Heldman AW, Hartert TV, Ray SC, et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomised comparison with parenteral therapy. Am J Med 1996;101:68-76
PubMed Web of Science ®Google Scholar
Ruis ME, Guerrero IC, Tuazon CU. Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid. Clin Infect Dis 2002;35:1018-20
PubMed Web of Science ®Google Scholar
Falagas ME, Blisiotis IA, Fragoulis KN. Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials. Am J Infect Control 2007;35:106-14
PubMed Web of Science ®Google Scholar
Riedel DJ, Weekes E, Forrest GN. Addition of rifampin in the management of native valve Staphylococcus aureus endocarditis [abstract: L610]. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2007 September 17 – 20; Chicago, USA
Google Scholar
Peterson LR, Quick JN, Jensen B, et al. Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S. aureus colonisation. Arch Intern Med 1990;150:2151-5
PubMed Web of Science ®Google Scholar
Blumberg HM, Rimland D, Carroll DJ, et al. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis 1991;163:1279-85
PubMed Web of Science ®Google Scholar
Weber SG, Gold HS, Hooper DC, et al. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalised patients. Emerg Infect Dis 2003;9:1415-22
PubMed Web of Science ®Google Scholar
Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003 – 04 influenza season. Emerg Infect Dis 2006;12:894-9
PubMed Web of Science ®Google Scholar
Kravitz GR, Dries DJ, Peterson ML, Schlievert PM. Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 2005;40:941-7
PubMed Web of Science ®Google Scholar
Francis JS, Doherty MC, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005;40:100-7
PubMed Web of Science ®Google Scholar
Hamilton SM, Bryant AE, Carroll KC, et al. In vitro production of Panton-Valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections. Clin Infect Dis 2007;45:1550-8
PubMed Web of Science ®Google Scholar
Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002;359:753-9
PubMed Web of Science ®Google Scholar
Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999;29:1128-32
PubMed Web of Science ®Google Scholar
Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006;194:1761-70
PubMed Web of Science ®Google Scholar
Genestier AL, Michallet MC, Prevost G, et al. Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 2005;115:3117-27
PubMed Web of Science ®Google Scholar
Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotising pneumonia. Science 2007;315:1130-3
PubMed Web of Science ®Google Scholar
Wang R, Braughton KR, Kretschmer D, et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007;13:1510-4
PubMed Web of Science ®Google Scholar
Stevens DL. The role of vancomycin in the treatment paradigm. Clin Infect Dis 2006;42(Suppl 1):S51-7
Web of Science ®Google Scholar
Hidayat LK, Hsu DI, Quist R, et al. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 2006;166:2138-44
PubMed Web of Science ®Google Scholar
Lamer C, de Beco V, Soler P, et al. Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients. Antimicrob Agents Chemother 1993;37:281-6
PubMed Web of Science ®Google Scholar
Cruciani M, Gatti G, Lazzarini L, et al. Penetration of vancomycin into human lung tissue. J Antimicrob Chemother 1996;38:865-9
PubMed Web of Science ®Google Scholar
Moise PA, Forrest A, Bhavnani SM, et al. Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus. Am J Health Syst Pharm 2000;57(Suppl 2):S4-9
PubMed Web of Science ®Google Scholar
Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394-434
PubMed Web of Science ®Google Scholar
American Thoracic Society/Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and health care-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416
PubMed Web of Science ®Google Scholar
Rubinstein E, Cammarata S, Oliphant T, Wunderink R. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin Infect Dis 2001;32:402-12
PubMed Web of Science ®Google Scholar
Wunderink RG, Cammarata SK, Oliphant TH, Kollef MH. Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin Ther 2003;25:980-92
PubMed Web of Science ®Google Scholar
Tsuji BT, Rybak MJ, Cheung CM,et al. Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents. Diagn Microbiol Infect Dis 2007;58:41-7
PubMed Web of Science ®Google Scholar
Arbeit RD, Maki D, Tally FP, et al. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 2004;38:1673-81
PubMed Web of Science ®Google Scholar
Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006;355:653-65
PubMed Web of Science ®Google Scholar
Silverman JA, Mortin LI, Vanpraagh AD, et al. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis 2005;191:2149-52
PubMed Web of Science ®Google Scholar
Breedt J, Teras J, Gardovskis J, et al. Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam. Antimicrob Agents Chemother 2005;49:4658-66
PubMed Web of Science ®Google Scholar
Sacchidanand S, Penn RL, Embil JM, et al. Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomised, double-blind trial. Int J Infect Dis 2005;9:251-61
PubMed Web of Science ®Google Scholar
Ellis-Grosse EJ, Babinchak T, Dartois N, et al. The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam. Clin Infect Dis 2005;41(Suppl 5):S341-53
PubMed Web of Science ®Google Scholar
Billeter M, Zervos MJ, Chen AY, et al. Dalbavancin: a novel once-weekly lipoglycopeptide antibiotic. Clin Infect Dis 2008;46:577-83
PubMed Web of Science ®Google Scholar
Poulakou G, Giamarellou H. Oritavancin: a new promising agent in the treatment of infections due to gram-positive pathogens. Expert Opin Investig Drugs 2008;17:225-43
PubMed Web of Science ®Google Scholar
Leonard SN, Rybak MJ. Telavancin: an antimicrobial with a multifunctional mechanism of action for the treatment of serious gram-positive infections. Pharmacotherapy 2008;28:458-68
PubMed Web of Science ®Google Scholar
Jauregui LE, Babazadeh S, Seltzer E, et al. Randomised, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections. Clin Infect Dis 2005;41:1407-15
PubMed Web of Science ®Google Scholar
Stryjewski ME, O'Riordan WD, Lau WK, et al. Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria. Clin Infect Dis 2005;40:1601-7
PubMed Web of Science ®Google Scholar
Stryjewski ME, Chu VH, O'Riordan WD, et al. Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study. Antimicrob Agents Chemother 2006;50:862-7
PubMed Web of Science ®Google Scholar
Sader HS, Fritsche TR, Jones RN. Antimicrobial activities of ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2008;52:1153-5
PubMed Web of Science ®Google Scholar
Page MG. Anti-MRSA beta-lactams in development. Curr Opin Pharmacol 2006;6:480-5
PubMed Web of Science ®Google Scholar
Noel GJ, Bush K, Bagchi P, et al. A randomised, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections. Clin Infect Dis 2008;46:647-55
PubMed Web of Science ®Google Scholar
Talbot GH, Thye D, Das A, Ge Y. Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections. Antimicrob Agents Chemother 2007;51:3612-6
PubMed Web of Science ®Google Scholar
Stevens DL, Ma Y, Salmi DB, et al. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 2007;195:202-11
PubMed Web of Science ®Google Scholar
Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 1999;18:1096-100
PubMed Web of Science ®Google Scholar
Schlievert PM, Kelly JA. Clindamycin-induced suppression of toxic-shock syndrome – associated exotoxin production. J Infect Dis 1984;149:471
PubMed Web of Science ®Google Scholar
Dickgiesser N, Wallach U. Toxic shock syndrome toxin-1 (TSST-1): influence of its production by subinhibitory antibiotic concentrations. Infection 1987;15:351-3
PubMed Web of Science ®Google Scholar
Gemmell CG, Ford CW. Virulence factor expression by Gram-positive cocci exposed to subinhibitory concentrations of linezolid. J Antimicrob Chemother 2002;50:665-72
PubMed Web of Science ®Google Scholar
Bernardo K, Pakulat N, Fleer S, et al. Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrob Agents Chemother 2004;48:546-55
PubMed Web of Science ®Google Scholar
Stevens DL, Wallace RJ, Hamilton SM, Bryant AE. Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics. Clin Infect Dis 2006;42:729-30
PubMed Web of Science ®Google Scholar
West SK, Plantenga MS, Strausbaugh LJ. Use of decolonisation to prevent staphylococcal infections in various healthcare settings: results of an Emerging Infections Network survey. Infect Control Hosp Epidemiol 2007;28:1111-3
PubMed Web of Science ®Google Scholar
Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131-9
PubMed Web of Science ®Google Scholar
Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonisation in the United States, 2001 – 2002. J Infect Dis 2006;193:172-9
PubMed Web of Science ®Google Scholar
Rim JY, Bacon AE III. Prevalence of community-acquired methicillin-resistant Staphylococcus aureus colonisation in a random sample of healthy individuals. Infect Control Hosp Epidemiol 2007;28:1044-6
PubMed Web of Science ®Google Scholar
Farley JE, Ross T, Stamper P, et al. Prevalence, risk factors and molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) nasal colonisation and skin infection among newly arrested males in Baltimore, Maryland [abstract 271]. 46th Annual Meeting of Infectious Diseases Society of America; 2007 October 4 – 7; San Diego, USA
Google Scholar
Yang ES, Tan J, Rieg G, Miller LG. Body site colonisation prevalence in patients with community-associated methicillin-resistant Staphylococcus aureus infections [abstract 285]. 46th Annual Meeting of Infectious Diseases Society of America; 2007 October 4 – 7; San Diego, USA
Google Scholar
Reagan DR, Doebbeling BN, Pfaller MA, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991;114:101-6
PubMed Web of Science ®Google Scholar
Doebbeling BN, Reagan DR, Pfaller MA, et al. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. Arch Intern Med 1994;154:1505-8
PubMedGoogle Scholar
Raz R, Miron D, Colodner R, et al. A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonisation and skin infection. Arch Intern Med 1996;156:1109-12
PubMed Web of Science ®Google Scholar
Ellis MW, Griffith ME, Dooley DP, et al. Targeted intranasal mupirocin to prevent colonisation and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomised controlled trial. Antimicrob Agents Chemother 2007;51:3591-8
PubMed Web of Science ®Google Scholar
Mulvey MR, MacDougall L, Cholin B, et al. Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis 2005;11:844-50
PubMed Web of Science ®Google Scholar
Cook HA, Furuya EY, Larson E, et al. Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2007;44:410-3
PubMed Web of Science ®Google Scholar
Wendt C, Schinke S, Wurttemberger M, et al. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomised, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol 2007;28:1036-43
PubMed Web of Science ®Google Scholar
Kaplan SL. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J 2005;24:457-8
PubMed Web of Science ®Google Scholar
Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005;352:468-75
PubMed Web of Science ®Google Scholar
Huijsdens XW, van Santen-Verheuvel MG, Spalburg E, et al. Multiple cases of familial transmission of community-acquired methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2006;44:2994-6
PubMed Web of Science ®Google Scholar
Jones TF, Creech CB, Erwin P, et al. Family outbreaks of invasive community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2006;42:e76-8
Google Scholar
Zafar U, Johnson LB, Hanna M, et al. Prevalence of nasal colonisation among patients with community-associated methicillin-resistant Staphylococcus aureus infection and their household contacts. Infect Control Hosp Epidemiol 2007;28:966-9
PubMed Web of Science ®Google Scholar
Baptiste KE, Williams K, Willams NJ, et al. Methicillin-resistant staphylococci in companion animals. Emerg Infect Dis 2005;11:1942-4
PubMed Web of Science ®Google Scholar
Weese JS, Dick H, Willey BM, et al. Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet Microbiol 2006;115:148-55
PubMed Web of Science ®Google Scholar
Manian FA. Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts. Clin Infect Dis 2003;36:e26-8
Google Scholar
van Duijkeren E, Wolfhagen MJ, Box AT, et al. Human-to-dog transmission of methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2004;10:2235-7
PubMed Web of Science ®Google Scholar
Rankin S, Roberts S, O'Shea K, et al. Panton valentine leukocidin (PVL) toxin positive MRSA strains isolated from companion animals. Vet Microbiol 2005;108:145-8
PubMed Web of Science ®Google Scholar
Johnston CP, Cooper L, Ruby W, et al. Epidemiology of community-acquired methicillin-resistant Staphylococcus aureus skin infections among healthcare workers in an outpatient clinic. Infect Control Hosp Epidemiol 2006;27:1133-6
PubMed Web of Science ®Google Scholar
Baggett HC, Hennessy TW, Rudolph K, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis 2004;189:1565-73
PubMed Web of Science ®Google Scholar
de Boer HE, van Elzelingen-Dekker CM, van Rheenen-Verberg CM, Spanjaard L. Use of gaseous ozone for eradication of methicillin-resistant Staphylococcus aureus from the home environment of a colonised hospital employee. Infect Control Hosp Epidemiol 2006;27:1120-2
PubMed Web of Science ®Google Scholar
Wiese-Posselt M, Heuck D, Draeger A, et al. Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonisation, 2002 – 2005. Clin Infect Dis 2007;44:e88-95
PubMed Web of Science ®Google Scholar
Miller LG, Diep BA. Clinical practice: colonisation, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008;46:752-60
PubMed Web of Science ®Google Scholar
McDougal LK, Steward CD, Killgore GE, et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003;41:5113-20
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Management and control strategies for community-associated methicillin-resistant Staphylococcus aureus

Bibliography

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Management and control strategies for community-associated methicillin-resistant Staphylococcus aureus

Bibliography

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date